BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

982 related articles for article (PubMed ID: 30661849)

  • 1. Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease.
    Totzeck M; Schuler M; Stuschke M; Heusch G; Rassaf T
    Int J Cardiol; 2019 Apr; 280():163-175. PubMed ID: 30661849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing cardio-oncology programs for cancer patients.
    Francis SA; Asnani A; Neilan T; Scherrer-Crosbie M
    Future Oncol; 2015; 11(14):2011-5. PubMed ID: 26198828
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiotoxic effects of chemotherapy: A review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system.
    Babiker HM; McBride A; Newton M; Boehmer LM; Drucker AG; Gowan M; Cassagnol M; Camenisch TD; Anwer F; Hollands JM
    Crit Rev Oncol Hematol; 2018 Jun; 126():186-200. PubMed ID: 29759560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardio-oncology: an ongoing evolution.
    Petek BJ; Greenman C; Herrmann J; Ewer MS; Jones RL
    Future Oncol; 2015; 11(14):2059-66. PubMed ID: 26198836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
    Lenneman CG; Sawyer DB
    Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardio-Oncology for the Primary Care Provider.
    Jhawar N; Mcpherson A; Chirila R; Ray J
    Rom J Intern Med; 2023 Sep; 61(3):127-134. PubMed ID: 37249550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Cardio-Oncology in the Interprofessional Care of Adult Patients Receiving Cancer Therapy.
    Pituskin E; Paterson I; Cox-Kennett N; Rothe D; Perri M; Becher H
    Semin Oncol Nurs; 2017 Nov; 33(4):384-392. PubMed ID: 28941563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
    Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
    CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Growing Impact of Cardiovascular Oncology: Epidemiology and Pathophysiology.
    Tufano A; Coppola A; Galderisi M
    Semin Thromb Hemost; 2021 Nov; 47(8):899-906. PubMed ID: 34255338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.
    Virani SA; Dent S; Brezden-Masley C; Clarke B; Davis MK; Jassal DS; Johnson C; Lemieux J; Paterson I; Sebag IA; Simmons C; Sulpher J; Thain K; Thavendiranathan P; Wentzell JR; Wurtele N; Côté MA; Fine NM; Haddad H; Hayley BD; Hopkins S; Joy AA; Rayson D; Stadnick E; Straatman L
    Can J Cardiol; 2016 Jul; 32(7):831-41. PubMed ID: 27343741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome.
    Tilemann LM; Heckmann MB; Katus HA; Lehmann LH; Müller OJ
    Clin Res Cardiol; 2018 Apr; 107(4):271-280. PubMed ID: 29453595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiotoxicity of anticancer therapies. Towards the implementation of cardio-oncology units].
    Hameau R; Gabrielli L; Garrido M; Guzmán AM; Retamal I; Vacarezza MJ; Greig D; Ocqueteau M; Sánchez C; Pizarro M; Corvalán A; Lavandero S; Castro PF; Martínez G
    Rev Med Chil; 2018 Jan; 146(1):68-77. PubMed ID: 29806680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Toxicities in Pediatric Cancer Survivors.
    Ryan TD; Nagarajan R; Godown J
    Cardiol Clin; 2019 Nov; 37(4):533-544. PubMed ID: 31587793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to Prevent Cardiotoxicity.
    Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
    Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practices in management of cancer treatment-related cardiovascular toxicity: A cardio-oncology survey.
    Jovenaux L; Cautela J; Resseguier N; Pibarot M; Taouqi M; Orabona M; Pinto J; Peyrol M; Barraud J; Laine M; Bonello L; Paganelli F; Barlesi F; Thuny F
    Int J Cardiol; 2017 Aug; 241():387-392. PubMed ID: 28365180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies - Part 2.
    Manolis AA; Manolis TA; Mikhailidis DP; Manolis AS
    Expert Opin Drug Saf; 2018 Sep; 17(9):893-915. PubMed ID: 30126303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardio-oncological management of patients.
    Cardinale DM; Barac A; Torbicki A; Khandheria BK; Lenihan D; Minotti G
    Semin Oncol; 2019 Dec; 46(6):408-413. PubMed ID: 31784042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment.
    Chow EJ; Leger KJ; Bhatt NS; Mulrooney DA; Ross CJ; Aggarwal S; Bansal N; Ehrhardt MJ; Armenian SH; Scott JM; Hong B
    Cardiovasc Res; 2019 Apr; 115(5):922-934. PubMed ID: 30768157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.
    Albini A; Pennesi G; Donatelli F; Cammarota R; De Flora S; Noonan DM
    J Natl Cancer Inst; 2010 Jan; 102(1):14-25. PubMed ID: 20007921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cardio-oncology Program: A Multidisciplinary Approach to the Care of Cancer Patients With Cardiovascular Disease.
    Parent S; Pituskin E; Paterson DI
    Can J Cardiol; 2016 Jul; 32(7):847-51. PubMed ID: 27343743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.